William Damsky MD

Dermatopathology

Assistant Professor of Dermatology and Pathology

2 Church St South Suite 305New Haven, CT 06510
Phone+1 203-785-4445
Fax+1 203-785-7637

Dr. Damsky is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Damsky's full profile Already have an account?

Education & Training

Yale-New Haven Medical CenterResidency, Dermatology, 2014 - 2017
Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2014
University of Vermont College of MedicineClass of 2013

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2022 - Present
CT State Medical License 2017 - 2027
American Board of Dermatology Dermatology
American Board of Dermatology Dermatopathology

Clinical Trials

Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare Start of enrollment: 2019 Apr 11
COMPLETED
PHASE1
Janus Kinase Inhibition in Sarcoidosis Start of enrollment: 2023 Jun 01
COMPLETED
PHASE2
Roles: Principal Investigator, Contact
Janus Kinase Inhibition in Granuloma Annulare Start of enrollment: 2023 Oct 27
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Sponsor-Investigator, Principal Investigator, Contact

Publications & Presentations

PubMed

Resolution of life- and limb-threatening pyoderma gangrenosum with spesolimab.
Anshu Jonnalagadda, Michael L Frisoli, Amar D Desai, Harjinder Chowdhary, William Damsky
JAAD Case Reports. 2026-08-01
Differential expression of immune checkpoint VISTA in inflammatory skin diseases.
Anjali Jaiswal, Eric Kim, Ümmügülsüm Yıldız-Altay, Rachel Breidbart, Michal Kidacki
The Journal of Investigative Dermatology. 2026-07-16
RNA in situ hybridization for ISG15 and IFI6 highlights IFN-I activity in discoid lupus erythematosus.
Jeff R Gehlhausen, Jeffrey M Cohen, Emily Baker, Sophia Luyten, Wilson Gipson
JID Innovations. 2026-07-01

Lectures

JAK Inhibitors: A New Frontier in Dermatology
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Press Mentions

Connecticut Magazine Names 24 Yale Dermatologists “Top Doctors”May 7th, 2026
Novel LDTs Advance Dermatological DiagnosticsFebruary 14th, 2025
TNF or JAK: Which Target Is Key to Success in Tough-to-Treat Skin Disease?November 11th, 2021